Results 11 to 20 of about 1,729,369 (285)

HIV Low-Level Viremia is Not Related to Subsequent Virological Failure Under NNRTI-Based Regimens: A Multicenter Retrospective Study in China [PDF]

open access: yesInfection and Drug Resistance
Xinmin Duan,1,2 Xiaojing Song,1 Wei Lyu,1 Yanling Li,1 Jing Tang,3 Wei Cao,1 Yang Han,1 Taisheng Li1,4 1Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing,
Duan X   +7 more
doaj   +4 more sources

Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya. [PDF]

open access: yesPLoS ONE, 2012
BACKGROUND: In resource-limited settings where viral load (VL) monitoring is scarce or unavailable, clinicians must use immunological and clinical criteria to define HIV virological treatment failure.
Cecilia Ferreyra   +14 more
doaj   +3 more sources

Determinants of virological failure and antiretroviral drug resistance in Mozambique [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2015
The objective of this study was to inform public health actions to limit first-line ART failure and HIV drug resistance in Mozambique.This was a cross-sectional study. HIV-1-infected adults on first-line ART for at least 1 year attending routine visits in the Manhiça District Hospital, in a semi-rural area in southern Mozambique with no HIV-1 RNA ...
Rupérez, María   +13 more
openaire   +5 more sources

Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case–control study

open access: yesHIV/AIDS: Research and Palliative Care, 2017
Belete Bayu,1 Amare Tariku,2 Abera Balcha Bulti,3 Yohannes Ayanaw Habitu,4 Terefe Derso,2 Destaw Fetene Teshome5 1Wag Himra Zonal Health Department, Sekota, 2Department of Human Nutrition, Institute of Public Health, 3Department of Internal Medicine ...
Bayu B   +5 more
doaj   +1 more source

Incidence, survival time and associated factors of virological failure among adult HIV/AIDS patients on first line antiretroviral therapy in St. Paul's Hospital Millennium Medical College-A retrospective cohort study.

open access: yesPLoS ONE, 2022
IntroductionHuman Immune deficiency Virus or Acquired Immune deficiency Syndrome (HIV/AIDS) is a pandemic affecting millions around the world. The 2020 the Joint United Nations Programme on HIV/AIDS report stated that the estimated number of people ...
Demeke Eshetu Andarge   +2 more
doaj   +2 more sources

Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa. [PDF]

open access: yesPLoS ONE, 2013
OBJECTIVE: This study aims to describe the virological, immunological and clinical efficacy of protease inhibitor (PI)-based second-line antiretroviral therapy (ART) in rural South Africa.
Annelot F Schoffelen   +5 more
doaj   +1 more source

Predicting Virologic Failure in an HIV Clinic [PDF]

open access: yesClinical Infectious Diseases, 2010
Abstract Background . We sought to use data captured in the electronic health record (EHR) to develop and validate a prediction rule for virologic failure among patients being treated for infection with human immunodeficiency virus (HIV). Methods .
Gregory K, Robbins   +6 more
openaire   +2 more sources

Performance of Immunological Response in Predicting Virological Failure [PDF]

open access: yesAIDS Research and Human Retroviruses, 2013
In HIV-infected individuals on antiretroviral therapy (ART), the decision on when to switch from first-line to second-line therapy is dictated by treatment failure, and this can be measured in three ways: clinically, immunologically, and virologically.
Nayana, Ingole   +4 more
openaire   +2 more sources

Induction with lopinavir-based treatment followed by switch to nevirapine-based regimen versus non-nucleoside reverse transcriptase inhibitors-based treatment for first line antiretroviral therapy in HIV infected children three years and older. [PDF]

open access: yesPLoS ONE, 2014
BACKGROUND:The World Health Organization recommends non-nucleoside reverse transcriptase inhibitors (NNRTIs)-based antiretroviral therapy (ART) for children three years and older.
Gerardo Alvarez-Uria   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy